Page last updated: 2024-10-26

dipyridamole and Deep Vein Thrombosis

dipyridamole has been researched along with Deep Vein Thrombosis in 6 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"Case 2: Three-yr-old boy with IgA deficiency and liver disease."1.38Budd-Chiari syndrome in children and outcome after liver transplant. ( Cipriano, A; Furtado, E; Gomes, AC; Gonçalves, I; Pinto, C; Rubino, G, 2012)
"Clinically symptomatic deep venous thrombosis was detected in association with four (0."1.34Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. ( Boutary, M; Dorr, LD; Gendelman, V; Long, WT; Maheshwari, AV; Wan, Z, 2007)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, RA1
Gandhi, AA1
Meng, H1
Yalavarthi, S1
Vreede, AP1
Estes, SK1
Palmer, OR1
Bockenstedt, PL1
Pinsky, DJ1
Greve, JM1
Diaz, JA1
Kanthi, Y1
Knight, JS1
Gomes, AC1
Rubino, G1
Pinto, C1
Cipriano, A1
Furtado, E1
Gonçalves, I1
Hankey, GJ1
Eikelboom, JW1
Moriau, M1
Lavenne-Pardonge, E1
Crasborn, L1
von Frenckell, R1
Col-Debeys, C1
Dorr, LD1
Gendelman, V1
Maheshwari, AV1
Boutary, M1
Wan, Z1
Long, WT1
Landolfi, R1
Di Gennaro, L1

Trials

1 trial available for dipyridamole and Deep Vein Thrombosis

ArticleYear
The treatment of severe or recurrent deep venous thrombosis. Beneficial effect of the co-administration of antiplatelet agents with or without rheological effects, and anticoagulants.
    Thrombosis research, 1995, Jun-15, Volume: 78, Issue:6

    Topics: Adult; Anticoagulants; Biomarkers; Blood Coagulation Tests; Blood Viscosity; Dipyridamole; Drug Ther

1995

Other Studies

5 other studies available for dipyridamole and Deep Vein Thrombosis

ArticleYear
Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome.
    Nature communications, 2019, 04-23, Volume: 10, Issue:1

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Antibodies, Antiphospholipid; Antiphospholipid S

2019
Budd-Chiari syndrome in children and outcome after liver transplant.
    Pediatric transplantation, 2012, Volume: 16, Issue:8

    Topics: Anticoagulants; Aspirin; Budd-Chiari Syndrome; Child, Preschool; Dipyridamole; Factor V; Female; Gas

2012
Antiplatelet drugs.
    The Medical journal of Australia, 2003, Jun-02, Volume: 178, Issue:11

    Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein G

2003
Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    The Journal of bone and joint surgery. American volume, 2007, Volume: 89, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replac

2007
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
    Haematologica, 2008, Volume: 93, Issue:3

    Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans;

2008